Raymond James & Associates’s First Trust Financials AlphaDEX Fund FXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$12.5M Sell
245,115
-11,264
-4% -$555K 0.01% 1090
2024
Q2
$11.9M Sell
256,379
-69,327
-21% -$3.19M 0.01% 1064
2024
Q1
$15.5M Buy
325,706
+35,969
+12% +$1.6M 0.01% 908
2023
Q4
$12.5M Sell
289,737
-63,821
-18% -$2.5M 0.01% 978
2023
Q3
$13.4M Sell
353,558
-39,071
-10% -$1.54M 0.01% 873
2023
Q2
$14.8M Sell
392,629
-308,565
-44% -$11.4M 0.01% 843
2023
Q1
$26.2M Buy
701,194
+89,687
+15% +$3.79M 0.02% 580
2022
Q4
$25M Sell
611,507
-5,182
-0.8% -$213K 0.02% 574
2022
Q3
$22.7M Sell
616,689
-10,937
-2% -$446K 0.02% 572
2022
Q2
$24.4M Buy
627,626
+201,617
+47% +$8.51M 0.02% 546
2022
Q1
$19.6M Buy
426,009
+65,827
+18% +$3.03M 0.02% 719
2021
Q4
$16.7M Buy
360,182
+34,691
+11% +$1.62M 0.01% 839
2021
Q3
$14.4M Buy
325,491
+22,738
+8% +$1.01M 0.01% 869
2021
Q2
$13.2M Buy
302,753
+33,418
+12% +$1.48M 0.01% 917
2021
Q1
$11.2M Buy
269,335
+81,778
+44% +$3.18M 0.01% 966
2020
Q4
$6.43M Sell
187,557
-20,053
-10% -$614K 0.01% 1190
2020
Q3
$5.27M Sell
207,610
-24,610
-11% -$641K 0.01% 1192
2020
Q2
$5.92M Sell
232,220
-105,811
-31% -$2.54M 0.01% 1086
2020
Q1
$7.15M Sell
338,031
-538,134
-61% -$16.1M 0.01% 882
2019
Q4
$29.4M Buy
876,165
+18,300
+2% +$595K 0.04% 421
2019
Q3
$27.3M Buy
857,865
+509,273
+146% +$16.1M 0.04% 425
2019
Q2
$11M Sell
348,592
-70,591
-17% -$2.2M 0.02% 803
2019
Q1
$12.7M Buy
419,183
+6,920
+2% +$207K 0.02% 699
2018
Q4
$11.1M Sell
412,263
-87,096
-17% -$2.57M 0.02% 706
2018
Q3
$16M Sell
499,359
-112,084
-18% -$3.62M 0.02% 618
2018
Q2
$19.2M Sell
611,443
-84,047
-12% -$2.65M 0.03% 523
2018
Q1
$21.6M Buy
695,490
+43,786
+7% +$1.39M 0.04% 439
2017
Q4
$20.4M Buy
651,704
+10,293
+2% +$315K 0.04% 466
2017
Q3
$19M Buy
641,411
+130,954
+26% +$3.8M 0.04% 474
2017
Q2
$14.6M Sell
510,457
-42,447
-8% -$1.18M 0.03% 550
2017
Q1
$15.3M Buy
552,904
+273,754
+98% +$7.61M 0.04% 501
2016
Q4
$7.54M Buy
279,150
+78,742
+39% +$2.01M 0.02% 771
2016
Q3
$4.87M Buy
200,408
+30,601
+18% +$737K 0.01% 956
2016
Q2
$3.93M Sell
169,807
-75,366
-31% -$1.75M 0.01% 982
2016
Q1
$5.54M Sell
245,173
-307,172
-56% -$6.6M 0.02% 775
2015
Q4
$12.8M Buy
552,345
+59,518
+12% +$1.4M 0.05% 433
2015
Q3
$11.1M Sell
492,827
-57,329
-10% -$1.35M 0.05% 452
2015
Q2
$13.1M Sell
550,156
-152,553
-22% -$3.65M 0.05% 426
2015
Q1
$16.6M Sell
702,709
-39,549
-5% -$918K 0.07% 294
2014
Q4
$17.3M Buy
742,258
+205,639
+38% +$4.65M 0.08% 259
2014
Q3
$11.7M Buy
536,619
+143,057
+36% +$3.18M 0.07% 310
2014
Q2
$8.76M Buy
393,562
+4,504
+1% +$97.9K 0.05% 408
2014
Q1
$8.49M Buy
389,058
+79,011
+25% +$1.69M 0.06% 372
2013
Q4
$6.74M Buy
310,047
+98,398
+46% +$2.05M 0.05% 417
2013
Q3
$4.18M Buy
211,649
+62,949
+42% +$1.24M 0.04% 543
2013
Q2
$2.79M Buy
+148,700
New +$2.75M 0.03% 662

Other funds holding FXO

Raymond James & Associates's FXO Position: Q3 2024 in Review

Raymond James & Associates reduced its First Trust Financials AlphaDEX Fund (FXO) stake by 4.4% in Q3 2024, selling an estimated $555K and leaving 245,115 shares worth $12.5M. The position accounts for 0.01% of the portfolio, ranked #1090.

Raymond James & Associates first reported a position in FXO in Q2 2013 and has held it in 46 quarters since. The position peaked at $29.4M in Q4 2019. 190 funds tracked by Wall St. Rank hold FXO as of Q3 2024.

  • Raymond James & Associates held 245,115 shares of First Trust Financials AlphaDEX Fund worth $12.5M as of Q3 2024.
  • Raymond James & Associates sold 11,264 First Trust Financials AlphaDEX Fund shares in Q3 2024, an estimated $555K.
  • First Trust Financials AlphaDEX Fund made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1090 holding.
  • Raymond James & Associates first reported a position in First Trust Financials AlphaDEX Fund in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's First Trust Financials AlphaDEX Fund position peaked at $29.4M in Q4 2019.
  • 190 funds tracked by Wall St. Rank held First Trust Financials AlphaDEX Fund as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.